ArticleCell reports2022

Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.

Rajappa S Kenchappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.